Mark Kashinskiy
Managing Partner – Founder
If your team is developing novel drug formulations, experimenting with synthesis, purification, or delivery methods to achieve therapeutic precision, you're likely owed a substantial R&D tax saving and/or refund.
Pharmaceutical labs perform research and development every single day.
If your team is developing novel drug formulations, experimenting with synthesis, purification, or delivery methods to achieve therapeutic precision, evaluating new pharmaceutical-grade compounds or excipients, you're likely owed a substantial R&D tax saving and/or refund.Whether you're designing alignment systems for high-tolerance optical assemblies, developing lightweight optics for advanced applications or simulating light behavior using ray-tracing, those costs may be eligible for R&D tax relief.
We help Founders, CTOs, and CFOs uncover overlooked credits tied to →
Built for high-growth tech.
We’ve secured over $100M in credits for innovators in advanceds manufacturing, aerospace, defense, and medical optics. Our team includes former Big 4 Tax CPAs, Tax Attorneys, and Engineers who speak your language - engineering and compliance.
We meet with your key staff to identify every qualifying project and disqualify any that don’t meet IRS criteria.
Our team reviews your payroll, general ledger, and tax returns to calculate the full credit.
A dedicated team with an impeccable IRS defense record reviews everything through our QA process.
You receive a complete, audit ready report that your CPA files alongside your taxes or amends for prior years.
Thanks to newly passed federal legislation, pharmaceutical companies may now have a chance to capture additional R&D benefits for 2022 or 2023. This opportunity is only available for a short window, so timing is critical.
Don’t leave six figures on the table.

Start with a no-obligation call to determine what your business could claim.